Add to watchlist

Summit Therapeutics Inc. (SMMT)

Last Price$19.1(7.5%)

Market Cap$14.6B

#SMMT Dividend Yield

#SMMT Dividend Per Share

#SMMT Dividend Payout Ratio

#Competing with SMMT Dividend

Overview

Ratings

Intrinsic Value

Valuation

Growth

Profitability

Health

Capital allocation

Momentum

Earnings

Dividends

Company name	Market Cap	Dividend Payout Ratio (LTM)	Cash Flow Payout Ratio (LTM)	DPS growth 1Y	DPS growth 3Y	DPS growth 10Y	Dividend Yield	Yield on Cost (1Y)	Yield on Cost (5Y)
Summit Therapeutics Inc.SMMT SMMT	$14.6B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
Novo Nordisk A/SNVO NVO	$402.0B	43.7%	63.0%	40.6%	29.5%	17.6%	1.5%	1.1%	4.5%
Vertex Pharmaceuticals IncorporatedVRTX VRTX	$125.5B	0.0%	0.0%	N/A	(100.0%)	N/A	0.0%	0.0%	0.0%
Regeneron Pharmaceuticals, Inc.REGN REGN	$74.0B	0.0%	0.0%	N/A	N/A	(100.0%)	0.0%	0.0%	0.0%
argenx SEARGX ARGX	$38.1B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
Alnylam Pharmaceuticals, Inc.ALNY ALNY	$31.3B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
BioNTech SEBNTX BNTX	$27.1B	0.0%	0.0%	(100.0%)	N/A	N/A	0.0%	0.0%	0.0%
Royalty Pharma plcRPRX RPRX	$15.2B	N/A	13.6%	7.9%	10.6%	(15.1%)	2.5%	2.8%	2.4%
Incyte CorporationINCY INCY	$14.8B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
United Therapeutics CorporationUTHR UTHR	$14.0B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
BeiGene, Ltd.BGNE BGNE	$1,846.9M	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%